Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.
SARS-CoV-2 Kappa variant
| Part of a series on the |
| COVID-19 pandemic |
|---|
 |
|
.svg){kind=small} COVID-19 portal |
Kappa variant[1] is a variant of SARS-CoV-2, the virus that causes COVID-19. It is one of the three sublineages of Pango lineage B.1.617. The SARS-CoV-2 Kappa variant is also known as lineage B.1.617.1 and was first detected in India in December 2020.[2] By the end of March 2021, the Kappa sub-variant accounted for more than half of the sequences being submitted from India.[3] On 1 April 2021, it was designated a Variant Under Investigation (VUI-21APR-01) by Public Health England.[4]
- ^ "Tracking SARS-CoV-2 variants". www.who.int. 31 May 2021. Retrieved 5 June 2021.
- ^ "Weekly epidemiological update on COVID-19 - 27 April 2021" (PDF). World Health Organization. 27 April 2021. Retrieved 6 June 2021.
- ^ Le Page, Michael (4 June 2021). "Indian covid-19 variant (B.1.617)". New Scientist. Retrieved 8 June 2021.
- ^ It was considered a previously circulating variant of interest by the World Health Organization on March 2022.SARS-CoV-2 variants of concern and variants under investigation in England - Technical briefing 10 (PDF) (Report). London. 7 May 2021. Retrieved 5 June 2021.
A variant first detected in India was designated under investigation on 1 April 2021 as VUI-21APR-01 (B.1.617.1).
{{cite report}}: Unknown parameter|agency=ignored (help)
This article incorporates text published under the British Open Government Licence v3.0:
Previous Page Next Page
